Rebecca Fett has a degree in molecular biology and biochemistry from the University of Sydney, Australia. Before becoming a full-time science writer, she performed laboratory research in the fields of bacterial gene expression, the microbiome, and cancer.
Rebecca then became an immunology specialist at a large law firm in New York, where she spent many years analyzing the scientific and clinical evidence for immune-targeting biologic medicines (such as Enbrel and Humira). Rebecca is passionate about translating complex science into plain english and sharing the latest the latest studies with those who can benefit.